Name: a quick phenotypic neurological scoring system for evaluating disease progression in the sod1-g93a mouse model of als
Uploaded: 2015-10-06T15:00:00
Description: Watch this Scientific Journal Video about A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS at JoVE.com

We would like to acknowledge Beth Levine for critically reviewing the manuscript, Valerie Tassinari for developing the genotyping protocol, and Matt Ferola and Carlos Maya for their exceptional animal care.

All experiments are conducted in accordance with the protocols described by the National Institutes of Health Guide for the Care and Use of Animals and were approved by ALS TDI&#8217;s institutional animal care and use committee (IACUC).
1. Animals, Housing, and Study Design
Note: The SOD1-G93A mouse colony was derived from the high copy B6SJLTgN(SOD1G93A)1Gur strain originally produced by Gurney et al. 7. The colony is currently being mai...

<ol>
	<li>Gurney, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Motor+neuron+degeneration+in+mice+that+express+a+human+Cu,Zn+superoxide+dismutase+mutation.">Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.</a> Science. 264 (5166), 1772-1775 (1994).</li><li>Rosen, D. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mutations+in+Cu/Zn+superoxide+dismutase+gene+are+associated+with+familial+amyotrophic+lateral+sclerosis.">Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.</a> Nature. 362 (6415), 59-62 (1993).</li><li>Gurney, M. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+use+of+transgenic+mouse+models+of+amyotrophic+lateral+sclerosis+in+preclinical+drug+studies.">The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.</a> J Neurol Sci. 152, Suppl. 1 (6415), (1997).</li><li>Scott, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Design,+power,+and+interpretation+of+studies+in+the+standard+murine+model+of+ALS.">Design, power, and interpretation of studies in the standard murine model of ALS.</a> Amyotroph Lateral Scler. 9 (1), 4-15 (2008).</li><li>Hegedus, J., Putman, C. T., Gordon, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Time+course+of+preferential+motor+unit+loss+in+the+SOD1+G93A+mouse+model+of+amyotrophic+lateral+sclerosis.">Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.</a> Neurobiol. Dis. 28 (2), 154-164 (2007).</li><li>Gordon, T., Ly, V., Hegedus, J., Tyreman, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Early+detection+of+denervated+muscle+fibers+in+hindlimb+muscles+after+sciatic+nerve+transection+in+wild+type+mice+and+in+the+G93A+mouse+model+of+amyotrophic+lateral+sclerosis.">Early detection of denervated muscle fibers in hindlimb muscles after sciatic nerve transection in wild type mice and in the G93A mouse model of amyotrophic lateral sclerosis.</a> Neurol. Res. 31 (1), 28-42 (2009).</li><li>Gurney, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Motor+neuron+degeneration+in+mice+that+express+a+human+Cu,Zn+superoxide+dismutase+mutation.">Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.</a> Science. 264 (5166), 1772-1775 (1994).</li><li>Kim, K., Moore, D. H., Makriyannis, A., Abood, M. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=AM1241,+a+cannabinoid+CB2+receptor+selective+compound,+delays+disease+progression+in+a+mouse+model+of+amyotrophic+lateral+sclerosis.">AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.</a> Eur. J. Pharmacol. 542 (1-3), 1-3 (2006).</li><li>Weydt, P., Hong, S. Y., Kliot, M., Moller, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessing+disease+onset+and+progression+in+the+SOD1+mouse+model+of+ALS.">Assessing disease onset and progression in the SOD1 mouse model of ALS.</a> Neuroreport. 14 (7), 1051-1054 (2003).</li><li>Azari, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Behavioural+and+anatomical+effects+of+systemically+administered+leukemia+inhibitory+factor+in+the+SOD1(G93A+G1H)+mouse+model+of+familial+amyotrophic+lateral+sclerosis.">Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A G1H) mouse model of familial amyotrophic lateral sclerosis.</a> Brain Res. 982 (1), 92-97 (2003).</li><li>Guan, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Thiazolidinediones+expand+body+fluid+volume+through+PPARgamma+stimulation+of+ENaC-mediated+renal+salt+absorption.">Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.</a> Nat. Med. 11 (8), 861-866 (2005).</li><li>Savcheniuk, O. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+effect+of+probiotic+therapy+on+development+of+experimental+obesity+in+rats+caused+by+monosodium+glutamate.">The effect of probiotic therapy on development of experimental obesity in rats caused by monosodium glutamate.</a> Fiziol. Zh. 60 (2), 63-69 (2014).</li><li>Smittkamp, S. E., Brown, J. W., Stanford, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Time-course+and+characterization+of+orolingual+motor+deficits+in+B6SJL-Tg(SOD1-G93A)1Gur/J+mice.">Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.</a> Neuroscience. 151 (2), 613-621 (2008).</li><li>C, M., Gurney, M. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+low+expressor+line+of+transgenic+mice+carrying+a+mutant+human+Cu,Zn+superoxide+dismutase+(SOD1)+gene+develops+pathological+changes+that+most+closely+resemble+those+in+human+amyotrophic+lateral+sclerosis.">A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis.</a> Acta Neuropathol. 93 (6), 537-550 (1997).</li><li>Wegorzewska, I., Baloh, R. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=TDP-43-based+animal+models+of+neurodegeneration:+new+insights+into+ALS+pathology+and+pathophysiology.">TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.</a> Neurodegener. Dis. 8 (4), 262-274 (2011).</li><li>Hatzipetros, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=C57BL/6J+congenic+Prp-TDP43A315T+mice+develop+progressive+neurodegeneration+in+the+myenteric+plexus+of+the+colon+without+exhibiting+key+features+of+ALS.">C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.</a> Brain Res. 1584, 59-72 (2014).</li></ol>

In this report, we describe a quick and simple video protocol which, if properly applied, is capable of reliably assessing the disease progression in SOD1-G93A mice and identifying drug-induced changes. While different groups have developed phenotypic scoring systems for SOD1-G93A mice 8-10, they often do not provide sufficient details on the procedure and are inadequate for replication. As a result, scoring systems are rarely used outside the specific group that develops them. In this report, the combination ...

Ever since its development in the mid 1990&#8217;s the SOD1-G93A transgenic mouse model has been the most widely used animal model of amyotrophic lateral sclerosis (ALS) 1. This transgenic mouse model was genetically engineered to overexpress a mutant form of the human Cu/Zn superoxide dismutase 1(SOD1) gene harboring the ALS-associated glycine to alanine mutation at amino acid 93 (G93A). The G93A mutation is one of many mutations in the SOD1 gene that collectively make-up approximately one fifth of familial ALS cases 2.
The SOD1-G93A model has become a workhorse of ALS drug development research because in addition to its obvious genetic link to ALS, it recapitulates many of the pathological features of ALS in humans such as motor neuron loss, progressive muscle weakness and atrophy, with eventual paralysis and death 3. Though, as is often the case with transgenic animal models, there is an inherent biological variability associated with SOD1-G93A mice. Scott et al. have determined that cohorts of at least 24 litter-matched gender-balanced mice are needed in drug-efficacy study designs in order to overcome the noise created by the biological variability 4. The large number of animals required in these studies in combination with the aggressive disease progression and the need for daily monitoring prohibits the use of elaborate, time-consuming and potentially stressful techniques for measuring neuromuscular strength and function (e.g., electromyography, grip strength, rotorod, etc.). Instead, it highlights the need for an in vivo screening tool that reliably assesses the neuromuscular function of SOD1-G93A mice in a quick manner.
At ALS TDI a protocol was developed that allows for the reliable assessment of the neuromuscular function of SOD1-G93A mice in less than 30 sec&#160;per mouse on average. This protocol encompasses daily assessment of hindlimb function using a simple neurological scoring system (NeuroScore) which is described in this report in press and in video. NeuroScore is focused on hindlimb function because hindlimb deficits are the earliest reported neurological sign of disease in SOD1-G93A mice 5,6. Further, the protocol developed by ALS TDI provides an unbiased assessment of onset of paresis (slight or partial paralysis), progression and severity of paralysis and it is sensitive enough to identify drug-induced changes in disease progression.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>B6SJLTgN(SOD1G93A)1Gur strain</td>
			<td>The Jackson Laboratory, Bar Harbor, ME</td>
			<td>002726</td>
			<td>Strain of mice used in this study</td>
		</tr>
		<tr>
			<td>Breeders</td>
			<td>Biomedical Research Models, Inc., Worcester, MA</td>
			<td></td>
			<td>Colony maintainance</td>
		</tr>
		<tr>
			<td>Scale</td>
			<td>Navigator OHAUS, Parsippany, NJ</td>
			<td>Model N14120</td>
			<td>Used to weigh mice</td>
		</tr>
		<tr>
			<td>Nutra-GelH</td>
			<td>Bio-Serv, Flemington, NJ</td>
			<td>#S4798</td>
			<td>Wet food provided to sick mice</td>
		</tr>
		<tr>
			<td>Irradiated Lab Animal Diet</td>
			<td>Harlan, Indianapolis, IN</td>
			<td>2918-111914M</td>
			<td>Chow diet</td>
		</tr>
		<tr>
			<td>Lab-grade Sani-chips</td>
			<td>Harlan Teklad, Indianapolis, IN</td>
			<td>7090</td>
			<td>Bedding</td>
		</tr>
		<tr>
			<td>JMPH&#160;</td>
			<td>SAS Institute, Inc., SAS Campus Drive, Cary, NC</td>
			<td>&#160;v10.0.2</td>
			<td>Statistical software</td>
		</tr>
		<tr>
			<td>Microsoft Excel</td>
			<td>Microsoft, One Microsoft Way, Redmond, WA</td>
			<td>Excel 2013 (v 15.0)</td>
			<td>Spreadsheet software</td>
		</tr>
		<tr>
			<td>GraphPad Prism 5</td>
			<td>GraphPad software Inc., La Jolla, CA</td>
			<td>v5.4</td>
			<td>Graphing software</td>
		</tr>
		<tr>
			<td>Mouse Huts</td>
			<td>Bio-Serv, Flemington, NJ</td>
			<td>K3272</td>
			<td>For environmental enrichment</td>
		</tr>
	</tbody>
</table>

a quick phenotypic neurological scoring system for evaluating disease progression in the sod1-g93a mouse model of als

The SOD1-G93A transgenic mouse is the most widely used animal model of amyotrophic lateral sclerosis (ALS). At ALS TDI we developed a phenotypic screening protocol, demonstrated in video herein, which reliably assesses the neuromuscular function of SOD1-G93A mice in a quick manner. This protocol encompasses a simple neurological scoring system (NeuroScore) designed to assess hindlimb function. NeuroScore is focused on hindlimb function because hindlimb deficits are the earliest reported neurological sign of disease in SOD1-G93A mice. The protocol developed by ALS TDI provides an unbiased assessment of onset of paresis (slight or partial paralysis), progression and severity of paralysis and it is sensitive enough to identify drug-induced changes in disease progression. In this report, the combination of a detailed manuscript with video minimizes scoring ambiguities and inter-experimenter variability thus allowing for the protocol to be adopted by other laboratories and enabling comparisons between studies taking place at different settings. We believe that this video protocol can serve as an excellent training tool for present and future ALS researchers.

The neurological score data for 90 male and 94 female non-treated SOD1-G93A mice studied at ALS TDI during 2014 were evaluated. The results show that male mice typically have a more aggressive disease progression than female mice, as evidenced by a greater proportion of their lifespan at NS 1 compared to females. NS 2 and NS 3 occur with virtually equal frequency across genders. NS 0 was excluded from the analysis because it is considered a &#8220;normal&#8221; phenotype. NS 4 was also excluded because by definition it c...

Watch this Scientific Journal Video about A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS at JoVE.com

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

This video protocol describes a sensitive, reliable, and quick method for evaluating the neuromuscular deficits in a transgenic mouse model of amyotrophic lateral sclerosis.

The SOD1-G93A transgenic mouse is the most widely used animal model of amyotrophic lateral sclerosis (ALS). At ALS TDI we developed a phenotypic screening ...

Research

JoVE Journal

Medicine

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

The unilaterally lesioned 6-hyroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) has proved to be invaluable in advancing our ...

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

Transcranial magnetic stimulation (TMS) has been in use for more than 20 years 1, and has grown exponentially in popularity over the past decade.  While ...

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder resulting in progressive degeneration of motoneurons. Peak of onset is around 60 ...

A Simple Method of Mouse Lung Intubation

A  simple procedure to intubate mice for pulmonary function measurements would  have several advantages in longitudinal studies with limited numbers or  ...

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Pancreatic cancer has an extremely poor five-year survival rate of 4-6%.  New therapeutic options are critically needed and depend on improved ...

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Urinary tract infections (UTI) are highly prevalent, a significant cause of morbidity and are increasingly resistant to treatment with antibiotics. ...

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

The aim of this manuscript and accompanying video is to provide an overview of the methods and approaches used for imaging heart valve function in ...

Evaluating the Procedure for Performing Awake Cystometry in a Mouse Model

Awake filling cystometry has been used for a long time to evaluate bladder function in freely moving mice, however, the specific methods used, vary among ...

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

The intrinsic tropism towards brain malignancies renders stem cells as promising carriers of therapeutic agents against malignant tumors. The delivery of ...

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Neuroinflammation is central to the pathological cascade following ischemic stroke. Non-invasive molecular imaging methods have the potential to provide ...